< Back to previous page
Project
A targeted nanomedicine strategy for in vivo CD8+ T cell engineering
The goal of this project is to investigate a strategy to target CD8+ T cells in vivo for subsequent cellspecific
delivery of nanoparticle-formulated therapeutics. Via this technology, we aim to modulate T cells in vivo in the blood and in the tumor microenvironment.
Date:1 Oct 2021 → 31 Oct 2022
Keywords:immunotherapy, nanotechnology, cancer, T cells
Disciplines:Nanomaterials, Biopharmaceuticals, Applied immunology, Pharmaceutical technology